Please login to the form below

Not currently logged in
Email:
Password:

Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

He takes up a seat on the company's board of directors

Amylyx Dr Walter GilbertThe founder and former chief executive officer of Biogen Dr Walter Gilbert has been elected to Amylyx Pharmaceuticals' board of directors.

The US-based pharmaceutical firm specialises in developing disease-modifying treatments for neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS).

Justin Klee, co-founder and president of Amylyx, said: “Dr Gilbert brings an enormous breadth of experience as a scientist, biotech founder and executive.

“We are honoured that he will join our efforts to advance AMX0035 for the treatment of ALS, which will be tested in an initial clinical trial in patients later this year.”

Over his 40-year career in industry and academia, Dr Gilbert founded several life sciences companies, including Biogen where he was chief executive officer and chairman of the board between 1981 and 1985, and Myriad Genetics where he continues to serve as vice chairman of its board of directors.

Dr Gilbert received the Nobel Prize in Chemistry in 1980 for the development of a rapid method of DNA sequencing, and is currently the Carl M. Loeb University Professor Emeritus at Harvard University.

He said: “Amylyx has assembled an outstanding team that is advancing an innovative approach to ALS and other neurodegenerative diseases.

“I am excited to help bring this promising therapeutic to patients.”

26th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics